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Purpose: The purpose of this study was to explore the prevalence of neurophysiological symptoms in 
patients with Joint Hypermobility Syndrome (JHS) and their impact on quality of life. 
Relevance: Clinical experience suggests that patients with JHS suffer from neurophysiological 
symptoms that contribute to skill and health impairments which might impact on quality of life. 
Methods A sample of 90 JHS-patients (mean age 34.7 ± 9.9 years), diagnosed according to the 
Brighton Criteria were compared with 113 healthy volunteers (mean age 35.7 ± 12.9) with no 
musculoskeletal pain. Neurophysiological symptoms were collected in a self report questionnaire. The 
Functional Difficulties Questionnaire was used for the assessment of developmental coordination 
disorder (DCD). A pain chart was employed to collect data relating to musculoskeletal pain. The SF-
12 medical outcomes questionnaire was used for assessing quality of life. 
Analysis: Chi-square was employed to compare group proportions. Continuous numerical data 
comparisons were analysed using independent sample t-tests. Regression analysis was employed to 
analyse multiple variables. 
Results: Patients with JHS were significantly more likely to report the following than healthy 
volunteers; autonomic symptoms (70%, 12%); gastrointestinal symptoms (71%, 9%); DCD (56%, 
19%) and chronic fatigue syndrome (31%, 1%). The mean number of pain sites reported for patients 
with JHS were 9.83 ± 4.18. Patients with JHS reported significantly lower physical component 
summary scores (PCS) of the SF-12 than healthy volunteers (p < 0.001). Pain was a significant 
predictor of reduced PCS of the SF-12 (p < 0.001) in a model that explained 23% of the variance. 
Conclusions Neurophysiological symptoms were common. Pain was a significant contributor to the 
health burden of patients with JHS. Further research is required to explore the implications of these 
symptoms in relation to the central nervous system. 
Implications: There is a requirement to acknowledge and understand the multidimensional nature of 
JHS.  
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